Comment from Network Contagion Research Institute | Health

Summary: NCRI Health, a working group at Rutgers University, advocates for identifying ME/CFS, Long Covid, POTS, Lyme-IACCI, and Fibromyalgia as priority disease areas for drug repurposing. They specifically recommend that the FDA expedite the review of low-dose naltrexone for these conditions, citing clinical evidence, real-world data, and a lack of commercial sponsorship for the drug.